All companies
XRHealth logo

XRHealth

Digital health / clinical softwareHealthcare AI and analytics

XRHealth delivers reimbursable therapeutic technology and clinician-led care across VR, AR, mobile apps, and wearables for people managing chronic conditions.

Problem & solution

Patients who need technology to manage chronic conditions often cannot find solutions their insurance covers, while providers lack the capacity and incentives to deploy standalone tools. XRHealth integrates prescribed devices, digital therapeutics, wearable data, AI-powered care plans, and a specialized clinical team into one at-home platform, with reimbursement designed into each modality.

Primary customers & users

Customers and channel partners include health plans, the VA, health systems, clinics, DME suppliers, and distributors. Decision-makers include payer medical and innovation leaders, health system executives, clinical leaders, procurement teams, clinic owners, and DME operators. Patients and technology-trained clinicians are the primary users.

Differentiation

XRHealth owns the full covered pathway from prescription to at-home therapy: reimbursable devices and digital therapeutics, its own distribution infrastructure, AI-powered care plans, and a specialized clinical network. Unlike standalone apps or devices, multiple modalities operate under one patient record and care plan.

Current traction

XRHealth’s revenue run rate grew 2.4x from $6.1M in January 2026 to $14.7M in July, when adjusted EBITDA reached positive $20K. Its VR device is FDA-registered, PDAC-verified, and reimbursable as DME. XRHealth has treated 50,000+ patients through 1M+ sessions, operates across 22 U.S. states, and reports 91% adherence. Partnerships include VA sites, Humana Medicare Advantage, and DME suppliers.

How Summit participants can help

We value introductions to health plans, VA leaders, health systems, clinics, DME networks, and distributors seeking reimbursable technology for chronic care. We also welcome strategic partnerships, acquisition opportunities involving reimbursable products or clinics, and investor relationships that can accelerate national scale.